- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Antidepressant Use Increases Risk of Hospital-Onset Clostridium Difficile Infection.
The incidence and severity of Clostridioides difficile infection (CDI) have risen in North America, the United Kingdom, and Europe. Limited evidence in the literature suggests a connection between CDI and antidepressant medication usage.
In his recent research, Antoine Boustany from Cleveland Clinic said, the use of mirtazapine, nortriptyline, or trazodone antidepressants increases the likelihood of contracting a CDI. The prevalence rate of this infection in patients who were using antidepressant medications and the ones who did not, increase with age
CDI is the most common cause of antibiotic-associated diarrhoea. Several risk factors have been implicated. In this study, researchers investigated whether the risk of developing CDI is increased in hospitalised patients using antidepressant medications.
The study included hospitalised patients and excluded those less than 18 years old. A multivariate regression analysis was performed to calculate the risk of CDI accounting for potential confounders.
Key insights from this research article are:
- CDI patients had female predilection.
- Patients with CDI had type 2 diabetes, inflammatory bowel disease, irritable bowel syndrome, smoking and alcohol use more common.
- The risk of CDI was no longer increased in patients using fluoxetine with OR, 0.94.
- The risk of CDI was more significant in those with inflammatory bowel disease patients using clindamycin, beta-lactam antibiotics, PPI, Trazadone, nortriptyline and mirtazapine.
They said, “This is the most extensive investigation to date that examines the risk of developing CDI in hospitalised patients who use antidepressant medications. Our findings reinforce the limited evidence present in the literature."
Reference:
Boustany, Antoine & Onwuzo, Somtochukwu & Abou Zeid, Hadi & Almomani, Ashraf & ASAAD, Imad. (2023). ANTIDEPRESSANT MEDICATIONS ARE ASSOCIATED WITH INCREASED RISK OF HOSPITAL-ACQUIRED CLOSTRIDIOIDES DIFFICILE INFECTION: A POPULATION-BASED STUDY. Arquivos de Gastroenterologia. 60. 309-314. 10.1590/s0004-2803.230302023-21.
BDS, MDS in Periodontics and Implantology
Dr. Aditi Yadav is a BDS, MDS in Periodontics and Implantology. She has a clinical experience of 5 years as a laser dental surgeon. She also has a Diploma in clinical research and pharmacovigilance and is a Certified data scientist. She is currently working as a content developer in e-health services. Dr. Yadav has a keen interest in Medical Journalism and is actively involved in Medical Research writing.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751